loader
Please Wait
Applying Filters...
menu
    • menu

    Information, Expiry & Status of Health Canada Patents covering Bilastine.

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Bilastine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,103Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Aralez Pharmaceuticals Canada Inc

    02 1Smart & Biggar

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Smart & Biggar

    Bilastine
    arrow
    Formnext Forum
    Not Confirmed

    Smart & Biggar

    Country
    arrow
    Formnext Forum
    Not Confirmed

    Patent Expiration Date : 2017-06-03

    Date Granted : 2007-01-23

    Bilastine

    Brand Name : BLEXTEN

    Patent Number : 2206754

    Filing Date : 1997-06-03

    Strength per Unit : 20 mg

    Dosage Form : TABLET

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2017-06-03

    Date Granted : 2007-01-23

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Aralez Pharmaceuticals Canad...

    Bilastine
    arrow
    Formnext Forum
    Not Confirmed

    Aralez Pharmaceuticals Canada Inc

    Country
    arrow
    Formnext Forum
    Not Confirmed

    Patent Expiration Date : 2022-04-19

    Date Granted : 2009-09-29

    Bilastine

    Brand Name : BLEXTEN

    Patent Number : 2484460

    Filing Date : 2002-04-19

    Strength per Unit : 20 mg

    Dosage Form : TABLET

    Human Or VET : Human

    Route of Administration : ORAL

    Patent Expiration Date : 2022-04-19

    Date Granted : 2009-09-29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF